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Acute type B hepatitis has been relatively uncommon among drug-abusers in Ireland until 
1980 when there was a marked increase in heroin addiction associated with the increased 
availability of this drug. Subsequently, there has been a continuing epidemic of acute hepatitis 
B in parenteral drug-abusers1 (Fig. 1). 
 The aim of this study was to investigate the extent of the spread of this epidemic to 
non-drug-abuser contacts of the parenteral drug-abusers; the mode of transmission of the 
infection to these patients; and to compare the hepatitis B serology in both parenteral and non-
drug abusers. 
 Methods and Patients 
Twenty-seven patients who were attending Cherry Orchard and the Federated Dublin 
Voluntary Hospitals who presented in the six months from July, 1981, with hepatitis B 
surface antigen (HBsAg) positive hepatitis and who denied parenteral drug abuse, were 
studied. Twenty-two male and six female HBsAg positive parenteral drug abusers from the 
same period of the epidemic were used for serological comparison. 
Serological Methods: Serological tests for all hepatitis B virus (HBV) markers were carried 
out at the Virus Reference Laboratory, Department of Medical Microbiology, U.C.D. using 
radio-immunoassay (RIA, Abbott Ausria II) for the detection of HBsAg with overnight 
incubation at 45°C to increase sensitivity and immunodiffusion (ID) for the detection of 
hepatitis B e antigen (HBeAg) and antibody (anti-HBe) as previously described. HBsAg 
subtypes were determined by ID using in-house reagents prepared from haemophilic serum as 
previously described.2 
Follow-up Patients: Patients’ interviews were designed to determine the potential modes of 
non-parenteral transmission of hepatitis B. Interviews, with the exception of three in hospital, 
were conducted in the patients’ homes by a sociologist. Where possible, a blood sample was 
taken from patients and their close contacts. In one case, the interviewee was the patient’s 
spouse. 
 Seventeen of the twenty-seven patients initially included were finally selected. The 
reasons for exclusion were: two were no longer resident in Ireland, three proved impossible to 
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contact, despite numerous attempts, and five admitted to parenteral drug abuse at the 
interview despite previous denials. 
 All patients contacted were cooperative at interview with the exception of one patient 
who refused to name contacts but was otherwise helpful. Fifteen of the 17 patients contacted 
were resident in Dublin at the time of interview. 
 Results 
Following the epidemic in drug-abusers there has been a steady increase in the numbers of 
hepatitis B positive patients who were not drug abusers, a peak being attained 4 months later 
than the start of the epidemic in drug-abusers (Fig. 2). This epidemic has been mainly 
confined to Dublin where the number of cases among non-drug abusers has doubled in this 
time (Table 1). 
Patients: There were 11 male and 6 female patients. The mean age was 33 years (range 13-53 
years). Nine patients 
 
 
 
 
Table 1 
Number of HBsAg positive patients 1980-1981 
 Numbers of HbsAg 
positive patients 
 1980 1981 
Dublin:   
Drug Abusers 34 170 
Non-Drug Abusers 45 109 
Elsewhere* 07 15 
 86 294 
*Drug-abuse not determined 
Table 2 
Source of Hepatitis B 
SOURCE NO. OF PATIENTS 
Heterosexual 5+ (29%) 
Homosexual 2 (12%) 
*Occupational 4 (23 %) 
*Therapy 1 (6%) 
‘Shared utensils’ 2+ (12%) 
Carrier 1 (6%) 
Foreign travel 1 (6%) 
Unknown 1 (6%) 
 17  
+6/7 confirmed contact with drug abusers 
*contact with blood products 
Table 3 
Sub-Type of HBsAg compared to source of Hepatitis 
NO. OF PATIENTS 
SUBTYPE CONTACT 
ad ay 
Heterosexual – 5* 
Homosexual 2 – 
*Occupational 2 2 
*Therapy – 2* 
‘Shared utensils’ – 1 
Carrier 1 – 
Foreign travel 1 – 
Unknown – 1 
*6/7 confirmed contact with drug-abuser 
were single, 6 were married and 2 were separated from their spouses. Seven patients had 
families ranging in size from 1 to 7 children; two patients had illegitimate children. 
Occupations ranged from higher professional to unskilled worker and five were unemployed. 
Eleven patients were hospitalised and five were treated at home. One patient was a 13-year-
old haemophiliac who was asymptomatic and was diagnosed following serological testing at 
an annual check-up. Another patient was a carrier with normal liver function. 
 The course of the hepatitis was mild in most of the patients, with classic features and 
no complications; the mean hospital stay was three weeks. Four patients had a prolonged 
hospital course with persistent cholestasis and transaminases greater than 600 i.u. All made a 
complete recovery. 
Modes of Transmission: The main mode of transmission of hepatitis B to these patients was 
either contact with blood or blood products or sexual contact with persons already infected 
(Table 2). 
Blood or Blood Products: Five (29%) patients had contact with blood or blood products within 
the six months before their illness. One, the haemophiliac, had received a blood transfusion, 
while two laboratory technicians, one microbiologist and one nurse had had occupational 
contact. 
Sexual Contact: Seven patients are believed to have acquired their hepatitis by sexual contact 
within the six months prior to onset of hepatitis. Of these, four had sexual intercourse with 
their spouse or regular partner and all of these contacts were HBV infected parenteral drug-
abusers. One had sexual intercourse with his spouse who was a psychiatric nurse who had had 
hepatitis during 1981. Two had homosexual contact with unidentified persons, therefore the 
source of their hepatitis is less certain. However, hepatitis B has been shown to be endemic in 
homosexual males.3,4 
Other Contact: Two patients claimed that the only form of contact with HBV infected persons 
was sharing cooking and eating utensils.- Of the remaining three patients, one was a carrier, 
one could not recall any contact and in the third case the patient had been in the Far East 
where the HBsAG carrier rate is among the highest in the world.5 
Follow-up of Patients Contacts: Blood samples were taken from twenty close contacts of the 
patients in the study group. None of these contacts, including 13 sexual partners were either 
HBsAG or anti-HBs positive. 
Sub-Type of Virus: The sub-type of the HBsAG in the study group was ad in 6 (35%) and ay 
in 11 (65%). In the drug-abusers, the sub-type was ay in all 28 patients. When the sub-type of 
the virus was compared to the source of the hepatitis it was observed that the 7 patients whose 
contacts were drug abusers were all ay while those in whom the cause was either not 
established or occupational were either ay or ad (Table 3). 
 Discussion 
The spread of acute hepatitis B among parenteral drug abusers is well recognised.6,7,8 There is 
now considerable evidence of the importance of non-parenteral spread although the exact 
mechanism is not understood.9,10 
 This study has shown that the recent epidemic of hepatitis B was not confined to 
parenteral drug abusers in Dublin, but was followed 4 months later by an increase in hepatitis 
B among non-drug-abusers, doubling the expected number of cases. As the second outbreak 
occurred within the incubation period of hepatitis B, this suggests that the increase is due to 
spread from the HBV infected drug-abusers. 
 The results of the follow-up study illustrate the difficulties in carrying out this kind of 
survey and explain the relatively small number of patients eventually included. The main 
difficulty was in tracing and making contact with patients who had moved or did not wish to 
co-operate. Five patients from the original study group admitted to drug-abuse at the 
interview confirming previous reports that many drug-abusers will not admit to abuse in 
hospital for fear of hospital authorities or police, but are more likely to do so in an informal 
situation.8 
 Despite the small numbers, the results clearly show that the main source of infection 
was spread from parenteral drug-abusers to their sexual partners or other close contacts. 
Transmission of the virus by heterosexual contact varies from 25% to 50% and is associated 
with promiscuity in the infective phase,9,3 which may be the case here. It may also explain the 
absence of sexual transmission to the contacts of patients who had no connection with drug-
abusers, all of whom were monogamous. 
 The predominant sub-type of HBsAg in affected blood donors in Ireland is ad, 
although, with the increase in drug abusers, the ratio of ad/ay is now changing as the latter are 
all ay.11 The finding that all the contacts of the drug abusers in our study were the ‘ay’ sub-
type, suggests that the same virus was transmitted. 
 Only 2 of our study group were homosexuals and both had the ad sub-type. 
 An alarming observation was the number of medical and technical personnel who had 
been infected in the course of their work, demonstrating the increased risk to these workers as 
a result of this epidemic. The need for adequate protective regimes to prevent the spread of 
this virus among such personnel is highlighted. Ultimately this epidemic has increased the 
number of HBsAg positive patients in Ireland. Inevitably this will lead to an increase in the 
number of carriers and of patients with chronic liver disease, cirrhosis and eventually hepato-
cellular carcinoma.12 
 This study indicates that at present the groups most at risk of acquiring HBsAg positive 
hepatitis apart from drug abusers themselves, are their sexual partners and the medical and 
technical staff who care for them. The recent increase in the abuse of drugs and the lack of 
adequate control of their distribution has led to a far wider dissemination of the virus within 
our society than before. The implications for the overall health of this society are serious and 
should not be underrated. 
 Summary 
 A recent increase in hepatitis B among non-drug-abusers has been investigated. The 
evidence suggests that this increase is a direct result of spread from an earlier epidemic 
among drug-abusers since the timing of the increase was within the incubation period of 
hepatitis B and the subtype of the virus in these contacts was ay which is the predominant 
subtype in drug-abusers. A detailed follow-up on non-drug-abusers showed that the main 
mode of transmission was by sexual contact with intravenous drug-abusers. 
 This outbreak may have serious consequences for Ireland because as the number of 
HBsAg positive patients increases so will the incidence of chronic liver disease and possibly 
hepatoma. This is particularly important for the groups most at risk, namely, parenteral drug-
abusers, their contacts and the medical and technical staff who care for them. 
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